Response to Markota et al. “Clinical heterogeneity and ECT in patients with clozapine resistant schizophrenia” SCHRES-D-24-00481

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Schizophrenia research 2024-10, Vol.272, p.110-111
Hauptverfasser:	Elkis, Helio, Melzer-Ribeiro, Debora Luciana, Napolitano, Isabel Cristina
Format:	Artikel
Sprache:	eng
Schlagworte:	Antipsychotic Agents - pharmacology Clozapine - pharmacology Clozapine - therapeutic use Electroconvulsive Therapy Humans Schizophrenia - drug therapy Schizophrenia, Treatment-Resistant - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	111
container_issue
container_start_page	110
container_title	Schizophrenia research
container_volume	272
creator	Elkis, Helio Melzer-Ribeiro, Debora Luciana Napolitano, Isabel Cristina
description
doi_str_mv	10.1016/j.schres.2024.08.003
format	Article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3099803497</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0920996424003748</els_id><sourcerecordid>3099803497</sourcerecordid><originalsourceid>FETCH-LOGICAL-c241t-2c4ed64c4f2c94262e9517c8b1281e19c2e4af97ad1323839977509d2a659f663</originalsourceid><addsrcrecordid>eNp9kLtuFDEUhi0EIkvgDRBySTPD8WUubpDQsBCkIKQk1JbjOcN6mbUH2wtKqhQ8BrxcngRHGyipTvPfzkfIcwY1A9a-2tbJbiKmmgOXNfQ1gHhAVqzpRMUbUA_JChSHSqlWHpEnKW0BgDXQPSZHQnEmgcOK_DzDtASfkOZAP5r4NWRDMVMz1_T25tcwO--smekGM8bwBT26fEWNH-l6uKDO08Vkhz4n-sPlDbVzuDaL80jLMpey8ZmWme46LGWrd-b25jc9H07O1ufV24rLCkD27Cl5NJk54bP7e0w-v1tfDCfV6af3H4Y3p5XlkuWKW4ljK62cuFWStxxVwzrbXzLeM2TKcpRmUp0ZmeCiF0p1XQExctM2ampbcUxeHnKXGL7tMWW9c8niPBuPYZ-0AKV6EFJ1RSoPUhtDShEnvUS3M_FKM9B3_PVWH_jrO_4ael34F9uL-4b95Q7Hf6a_wIvg9UGA5c_vDmNJKfwsji6izXoM7v8NfwDTspkF</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3099803497</pqid></control><display><type>article</type><title>Response to Markota et al. “Clinical heterogeneity and ECT in patients with clozapine resistant schizophrenia” SCHRES-D-24-00481</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Elkis, Helio ; Melzer-Ribeiro, Debora Luciana ; Napolitano, Isabel Cristina</creator><creatorcontrib>Elkis, Helio ; Melzer-Ribeiro, Debora Luciana ; Napolitano, Isabel Cristina</creatorcontrib><identifier>ISSN: 0920-9964</identifier><identifier>ISSN: 1573-2509</identifier><identifier>EISSN: 1573-2509</identifier><identifier>DOI: 10.1016/j.schres.2024.08.003</identifier><identifier>PMID: 39214020</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Antipsychotic Agents - pharmacology ; Clozapine - pharmacology ; Clozapine - therapeutic use ; Electroconvulsive Therapy ; Humans ; Schizophrenia - drug therapy ; Schizophrenia, Treatment-Resistant - drug therapy</subject><ispartof>Schizophrenia research, 2024-10, Vol.272, p.110-111</ispartof><rights>2024 Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c241t-2c4ed64c4f2c94262e9517c8b1281e19c2e4af97ad1323839977509d2a659f663</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0920996424003748$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39214020$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Elkis, Helio</creatorcontrib><creatorcontrib>Melzer-Ribeiro, Debora Luciana</creatorcontrib><creatorcontrib>Napolitano, Isabel Cristina</creatorcontrib><title>Response to Markota et al. “Clinical heterogeneity and ECT in patients with clozapine resistant schizophrenia” SCHRES-D-24-00481</title><title>Schizophrenia research</title><addtitle>Schizophr Res</addtitle><subject>Antipsychotic Agents - pharmacology</subject><subject>Clozapine - pharmacology</subject><subject>Clozapine - therapeutic use</subject><subject>Electroconvulsive Therapy</subject><subject>Humans</subject><subject>Schizophrenia - drug therapy</subject><subject>Schizophrenia, Treatment-Resistant - drug therapy</subject><issn>0920-9964</issn><issn>1573-2509</issn><issn>1573-2509</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kLtuFDEUhi0EIkvgDRBySTPD8WUubpDQsBCkIKQk1JbjOcN6mbUH2wtKqhQ8BrxcngRHGyipTvPfzkfIcwY1A9a-2tbJbiKmmgOXNfQ1gHhAVqzpRMUbUA_JChSHSqlWHpEnKW0BgDXQPSZHQnEmgcOK_DzDtASfkOZAP5r4NWRDMVMz1_T25tcwO--smekGM8bwBT26fEWNH-l6uKDO08Vkhz4n-sPlDbVzuDaL80jLMpey8ZmWme46LGWrd-b25jc9H07O1ufV24rLCkD27Cl5NJk54bP7e0w-v1tfDCfV6af3H4Y3p5XlkuWKW4ljK62cuFWStxxVwzrbXzLeM2TKcpRmUp0ZmeCiF0p1XQExctM2ampbcUxeHnKXGL7tMWW9c8niPBuPYZ-0AKV6EFJ1RSoPUhtDShEnvUS3M_FKM9B3_PVWH_jrO_4ael34F9uL-4b95Q7Hf6a_wIvg9UGA5c_vDmNJKfwsji6izXoM7v8NfwDTspkF</recordid><startdate>202410</startdate><enddate>202410</enddate><creator>Elkis, Helio</creator><creator>Melzer-Ribeiro, Debora Luciana</creator><creator>Napolitano, Isabel Cristina</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202410</creationdate><title>Response to Markota et al. “Clinical heterogeneity and ECT in patients with clozapine resistant schizophrenia” SCHRES-D-24-00481</title><author>Elkis, Helio ; Melzer-Ribeiro, Debora Luciana ; Napolitano, Isabel Cristina</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c241t-2c4ed64c4f2c94262e9517c8b1281e19c2e4af97ad1323839977509d2a659f663</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Antipsychotic Agents - pharmacology</topic><topic>Clozapine - pharmacology</topic><topic>Clozapine - therapeutic use</topic><topic>Electroconvulsive Therapy</topic><topic>Humans</topic><topic>Schizophrenia - drug therapy</topic><topic>Schizophrenia, Treatment-Resistant - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Elkis, Helio</creatorcontrib><creatorcontrib>Melzer-Ribeiro, Debora Luciana</creatorcontrib><creatorcontrib>Napolitano, Isabel Cristina</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Schizophrenia research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Elkis, Helio</au><au>Melzer-Ribeiro, Debora Luciana</au><au>Napolitano, Isabel Cristina</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Response to Markota et al. “Clinical heterogeneity and ECT in patients with clozapine resistant schizophrenia” SCHRES-D-24-00481</atitle><jtitle>Schizophrenia research</jtitle><addtitle>Schizophr Res</addtitle><date>2024-10</date><risdate>2024</risdate><volume>272</volume><spage>110</spage><epage>111</epage><pages>110-111</pages><issn>0920-9964</issn><issn>1573-2509</issn><eissn>1573-2509</eissn><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>39214020</pmid><doi>10.1016/j.schres.2024.08.003</doi><tpages>2</tpages></addata></record>
fulltext	fulltext
identifier	ISSN: 0920-9964
ispartof	Schizophrenia research, 2024-10, Vol.272, p.110-111
issn	0920-9964 1573-2509 1573-2509
language	eng
recordid	cdi_proquest_miscellaneous_3099803497
source	MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects	Antipsychotic Agents - pharmacology Clozapine - pharmacology Clozapine - therapeutic use Electroconvulsive Therapy Humans Schizophrenia - drug therapy Schizophrenia, Treatment-Resistant - drug therapy
title	Response to Markota et al. “Clinical heterogeneity and ECT in patients with clozapine resistant schizophrenia” SCHRES-D-24-00481
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T21%3A05%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Response%20to%20Markota%20et%20al.%20%E2%80%9CClinical%20heterogeneity%20and%20ECT%20in%20patients%20with%20clozapine%20resistant%20schizophrenia%E2%80%9D%20SCHRES-D-24-00481&rft.jtitle=Schizophrenia%20research&rft.au=Elkis,%20Helio&rft.date=2024-10&rft.volume=272&rft.spage=110&rft.epage=111&rft.pages=110-111&rft.issn=0920-9964&rft.eissn=1573-2509&rft_id=info:doi/10.1016/j.schres.2024.08.003&rft_dat=%3Cproquest_cross%3E3099803497%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3099803497&rft_id=info:pmid/39214020&rft_els_id=S0920996424003748&rfr_iscdi=true